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Descriptors calculated from molecular structures have been used to map different areas of chemical space. A
number of applications for such maps can be identified, ranging from the fine-tuning and optimisation of catalytic
activity and compound properties to virtual screening of novel compounds, as well as the exhaustive exploration of
large areas of chemical space by automated combinatorial building and evaluation. This review focuses on organometallic
catalysis, but also touches on other areas where similar approaches have been used, with a view to assessing the extent
to which chemical space has been explored.
Keywords: Chemical space, Computational chemistry, Design of experiments, Structure–property relationships,
Chemoinformatics, Drug discovery, Organometallic catalysis, Principal component analysisIntroduction
Much of modern life relies on maps of familiar and
foreign territories, whether they are used to plan a
journey, deliver goods to the right address, or to dis-
play information about the health and wealth of
people. Maps were once a luxury of the ruling classes
and often woefully inadequate, but nowadays satellite
mapping and the global positioning system (GPS) put
a wealth of information in the hands of ordinary citi-
zens at a variety of scales and resolutions, and both
terra incognita and “there be dragons” have become
relics of the past. And while many areas of science
are also getting mapped in different ways, ranging
from the universe and other planets to the genomes
of living creatures and the properties of elements in
the periodic table, graphical depictions of the whole
universe of chemically-accessible molecules are rare
and substantially incomplete.
There is an issue of scale, where, even when limit-
ing it to organic chemical space, usually involving
compounds of C, H, N, O, S and the halides, as well
as P in some cases, and restricting compound size to
drug-like molecules of interest to the pharmaceutical in-
dustry, somewhere between 3.4 × 109 [1] and 1 × 10200
compounds [2] may need to be considered (1 × 1060 is the
number given most frequently [3, 4]). Of these, availableCorrespondence: Natalie.Fey@Bristol.ac.uk
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millions of structures [4], revealing a vast discrepancy be-
tween what has been synthesised/characterised and the
compounds we think could be made. Consideration of the
so-called chemical universe, extending beyond organic
compounds to encompass all areas of chemistry, lies even
further beyond our understanding, reach and data storage
capabilities.
The characterisation of unknown chemical compounds
relies on calculated property descriptors (the term pa-
rameters is commonly used interchangeably, especially
in organic and organometallic chemistry) and the com-
putational mapping of chemical space has become in-
creasingly viable with the growth of cheap computing
hardware, extensive data storage and networked elec-
tronic access. Arguably, the necessary software and com-
puting power are now within reach of many researchers
in the chemical sciences, and experiments of the future
may be preceded by a computational characterisation
of compounds of interest, which, when coupled with
predictive models, could lead to the selection and pri-
oritisation of the most promising synthetic routes and
products [4, 5].
In a world of increasingly scarce resources and tigh-
ter regulations, such an approach holds great promise
and this review will seek to provide an overview of recent
efforts (predominantly published since 2010) to map dif-
ferent areas of chemical space with calculated descriptorsstributed under the terms of the Creative Commons Attribution License (http://
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focus will be on representative examples from organomet-
allic homogeneous catalysis, bridging both catalyst devel-
opment and their applications to organic synthesis, some
forays into other areas of chemical space, especially target
substrates and products of catalysis, will also be men-
tioned, with a view to providing an idea of how much of




In broad terms, calculated property descriptors are proc-
essed into maps of chemical space1 for three different,
sometimes connected, purposes: 1) fine-tuning and opti-
misation, 2) screening and selection, and 3) exploration.
(Adapted from Yang, Beratan et al., ref. [6]).
In the development and improvement of catalytically
active complexes, ligands (i.e. ions or small molecules
binding to transition metal centres) are a convenient
way of fine-tuning catalyst performance once a viable re-
action has been optimised to be catalytic. Similarly, the
properties of a desirable product (e.g. a compound with
potential uses as a pharmaceutical) can be optimised by
varying its substituents. These improvements can be
guided by computation, allowing researchers to predict
the effect of modifications on a compound of interest
before its synthesis is carried out. Here both the inter-
pretation of available data on related compounds and
the likely mechanism of reaction, often in terms of the
relative importance of steric and electronic effects, and
the making of predictions for novel structures, may be
attempted. In consequence, 3D molecular structures are
generally calculated with electronic structure methods2
and used to determine relatively sophisticated descrip-
tors specific to the chemistry of interest, such as ligand
binding energies in organometallic complexes [7–10]
and IR stretching frequencies [8].
The area of selection includes automated virtual
screening to identify the most promising targets for syn-
thesis (note that it can also be used to identify protein
targets in medicinal chemistry, but this lies outside of
the scope of this review), but it can also mean evaluating
novel designs before their experimental realisation by
setting them into a context of known compounds, usu-
ally those with desirable properties. Here, fast structure
generation can become important for large-scale screen-
ing efforts [4], but 3D structures [11], albeit at times cal-
culated cheaply [12],3 are still used in smaller databases.
In addition, studies are likely to include a figure-of-merit,
related to the catalytic cycle [13, 14] or the key property
considered to affect properties and activity [15], to assess
structure–property/activity relationships more closely. Da-
tabases generated are often larger and descriptors can beselected for speed of their evaluation, sacrificing detailed
chemical interpretation to some extent.
Finally, where exploration is the main target, gener-
ation of a large and diverse set of molecular structures
(sometimes termed “exhaustive enumeration”) is as im-
portant as the fast characterisation of these structures
with suitable descriptors [6, 16]. Those which can be cal-
culated from simple structural formulae, i.e. topological
and 2D descriptors, are more likely to be used, as they
are often relatively cheap to calculate and will not re-
quire optimisation and conformational searching of 3D
structures.
As indicated above, there is some overlap between
these three reasons for mapping chemical space in indi-
vidual studies, e.g. an exhaustive exploration of chemical
space may later be followed by screening subsets of such
compounds with calculated figures of merit [16]. At the
other end of the spectrum, as datasets developed for op-
timisation grow in size and sample chemical space bet-
ter, they can be augmented with suitable calculated
figures of merit and then also used for virtual screening
[17]. Nevertheless, this classification provides a useful
link with the numbers of structures calculated, increas-
ing on going from fine-tuning to exploration (illustrated
in Fig. 1). Similarly, this links to the computational cost
per entry and the accuracy of the descriptors used, from
full quantum chemical structural characterisations to
fast calculations of topological descriptors, and, corres-
pondingly, from detailed mapping of structural and elec-
tronic properties, retaining close links to the mechanism
of reaction, to coarse bins of structural similarities.
Principal component analysis
In the extreme, only two or three descriptors may be
considered to characterise compounds, facilitating the
generation of maps from simple plots, such as Tolman’s
map of cone angles and electronic parameters [18, 19].
For larger databases with multiple (correlated) descrip-
tors, a range of statistical approaches are available to
convert data into maps of chemical space, and of these,
principal component analysis (PCA) is used most widely,
likely because the approach is implemented in many
data analysis packages. It is worth noting here that a
range of other approaches have been used, especially in
drug discovery, such as self-organising/Kohonen maps
(SOM), generative topographic maps (GTM) and a range
of clustering approaches, and these have recently been
reviewed [20]. While detailed discussions of this ap-
proach can be found in a variety of books (e.g. [21, 22],
it can be summarised in brief as follows:
PCA is a statistical projection approach which can be
used to capture correlated data in fewer, orthogonal di-
mensions, allowing data similarity to be visualised as dis-
tance in low-dimensional plots of the resulting principal
Fig. 1 Schematic illustrating the necessary trade-off between computational cost per entry and the number of structures considered in a
database of compounds characterised with calculated property descriptors
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original descriptors, with coefficients determined by a
constrained optimisation process, designed to capture as
much of the variation in the data set as possible in fewer,
orthogonal PCs. Nevertheless, the technique generates
the same number of derived descriptors as the original
dataset used, albeit of decreasing importance, such that
the first 3–5 PCs often capture 70–90 % of the variation
in the dataset. Coefficients (also called loadings) can be
used to determine the importance of individual descrip-
tors to the variation in the dataset and so derive inter-
pretations, but it is worth bearing in mind that PCA is
not statistically robust [7] and changes to the dataset
can substantially affect the PC composition, hindering
their detailed chemical interpretation. Nevertheless, a
rough resolution of steric and electronic effects can
often be achieved. Each compound in the database is
then described by its PC scores, and score plots (scatter
plots of the first few PCs) can be used to visualise the
data set, with points close in chemical space similar,
while increased distance relates to greater differences.
Focus on fine-tuning and optimisation
Organometallic chemistry has a well-established tradition
of using ligand descriptors to identify steric and electronic
effects on the properties and behaviours of transition
metal complexes [5, 18, 23], because ligands often provide
a convenient approach to the fine-tuning and optimisation
of complex properties. Similarly, organic chemistry relies
on a semi-quantitative understanding of the steric and
electronic properties of substituents, rooted to some
extent in Hammet and related substituent parameters
[24] used to identify linear free energy relationships. Ef-
forts in both fields have also sought to capture chirality
and hence make predictions about asymmetric inductionand selectivity [25–27]. Structure–property and structure-
reactivity relationships can help to interpret experimental
observations and, where sufficient data are available, even
to make predictions about related compounds for which
descriptors have been determined, but which have not
been studied experimentally.
In recent years, calculated parameters have gained in-
creasing acceptance in this area, not in the least because
these enable the consideration of novel compounds
before their synthesis is attempted. Perhaps the best-
characterised class of ligands are monodentate P-donor
ligands for which a range of approaches have been de-
scribed, and these have been reviewed in detail elsewhere
[18]. Possibly the biggest database for these ligands has
been developed by a consortium of academic research
groups at the University of Bristol and data for in excess of
350 ligands have been published to-date [7, 17, 28], with
over 1000 held in-house. Other types of ligands have also
been characterised computationally, including anionic li-
gands [29], carbenes [9, 30–32] and other C-donor ligands
[33], and bidentate P,P and P,N-donor ligands [34–36].
Some of these datasets have been processed into maps of
ligand space, either by plotting key descriptors against
each other directly [8, 37], or by processing multiple
descriptors with principal component analysis (Fig. 2
shows an example of the LKB-P map [28] of ligand space)
[7, 28, 30, 33–36] (for a brief summary of this statistical
method, see above). These maps can be used to quantify
ligand similarities and set ligands into context [28], allow-
ing evaluation of novel designs to precede synthesis. This
has recently been used by researchers in Bristol to predict
and then deliver novel fluorophosphine ligands R2PF, giv-
ing active catalysts for hydroformylation and hydrocyana-
tion, as suggested by their proximity to phosphite ligands
on the LKB-P map of ligand space [17] before synthesis.
Fig. 2 Map of ligand properties generated by principal component analysis of 28 ligand descriptors capturing the structures and energies of 348
P-donor ligands through DFT-calculated data, collected in LKB-P. [28] The principal components are linear combinations of the original descriptors
derived to capture most of the variation in fewer uncorrelated descriptors (65 % in this case). Each symbol corresponds to a ligand, and shape
and color are determined by substituents. Reprinted with permission from Ref. [28]. Copyright 2010 American Chemical Society
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range of response data from both experimental and
computational studies, allowing their interpretation (and
in some cases prediction) in terms of steric and elec-
tronic effects [14, 18, 28, 38]. Ligand effects on transi-
tion metal complexes are relatively subtle and it can be
challenging to separate steric and electronic effects, so
these studies generally rely on electronic structure calcu-
lations [18] (most commonly using density functional
theory (DFT), although some of these studies used semi-
empirical [8] and QM/MM approaches [37]) to optimise
structures and calculate/extract descriptors. The associ-
ated computational cost has limited the size of databases.
Ligand structures characterised by different computational
descriptors, albeit at detailed resolution, likely number in
the low thousands, with little overlap between different li-
gands,4 perhaps best compared to a map of the local area
or private garden.
Focus on selection and screening
Some of the ligand property maps generated from calcula-
tions with electronic structure methods and surveyed in
the preceding section have also been used to support cata-
lyst screening and experimental design (Design of Experi-
ments, DoE). This can take the form of simply projecting
a desirable property or response onto a map of ligand
space, as demonstrated with LKB-P (Fig. 3) [28, 39] and, if
a cluster of ligands is found to exhibit this property, test-
ing structures in the same area experimentally.
Where sufficient data for training regression models
are available, quantitative prediction can also be attempted
[12, 14, 28, 40]. Maps can be used to select ligands forexperimental screening, and their use with Design of Ex-
periment (DoE) approaches has recently been highlighted
by Moseley and Murray (M&M) [39], presenting a case
study of reaction optimisation for ruthenium and iridium
catalysis of borrowing hydrogen reactions (Scheme 1). In
experimental design, compound data is discrete, rather
than continuous [39], but its use is possible, and M&M
describe the use of a cube on 3D maps of ligand space gen-
erated from PCs1–3 to select compounds for screening.
However, databases developed primarily for screening
often use lower levels of theory to calculate descriptors,
although separation of steric and electronic effects is still
feasible, and the automated building of structures plays
a more important role. These issues have been explored
extensively by the group of Rothenberg based in
Amsterdam [15, 41] and the group have reported a
number of studies: Ligand and solvent effects have been
screened, [42, 43], using response data harvested from
the literature and combining it with a range of fast-to-
calculate 2D and 3D descriptors. In addition, the bite an-
gles and flexibility of bidentate P,P donor ligands have
been investigated by Rothenberg’s group, using topo-
logical descriptors, with a view to demonstrating that
cheap calculation approaches can give useful models for
prediction and so be applied to in silico screening of
large ligand and catalyst libraries [15]. A broader range
of descriptors was later used by the same group to evalu-
ate a library of ligands with a view to maximising their
diversity, mapping ligand diversity in 2D- and 3D space
[12]. This approach was also used to generate and evalu-
ate a catalyst library from fragments [40], a proof-of-
concept study designed to identify novel catalysts for
Fig. 3 Projection of FRET yields for palladium-catalyzed amination of aryl bromide [56] onto LKB-P map. [28] Spot size and coloring relate to yield,
with dark red, large spots corresponding to the highest yields (55, 69 %; 162, 80 %) and small yellow spots corresponding to lowest yields (77,
8 %; 310, 9 %). See original publication for ligand numbering. Reprinted with permission from Ref. [28]. Copyright 2010 American
Chemical Society
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the latter study provides little detail on the descriptors
used, nor indeed the novel ligand designs identified.
For organometallic catalysis, and alkene metathesis
(Scheme 2) catalysed by ruthenium carbene complexes
in particular, the group of Jensen based in Bergen cur-
rently leads in the automation of structure generation;
starting with ligand screening by a range of descriptors
available in chemoinformatics software [14], they have
since described the automated assembly and screening
of a broad range of ligands [13], as well as developing
their own modifications and rules to make approaches
from other areas of chemistry more suitable for organo-
metallic catalysis [11, 44]. These studies have adapted
combinatorial virtual synthesis algorithms for use with
transition metal centres, and combine this with a range
of descriptors and response data to pursue the discovery
of viable novel catalysts; they are not usually processed
into formal maps of chemical space, though.
Moving beyond the evaluation of organometallic com-
plexes, the virtual screening of drug-like molecules, ei-
ther based on their structures (evaluating similarity to










Scheme 1 Borrowing hydrogen model reaction optimised as described intheir interaction with known protein targets, is perhaps
the most substantial field using calculated descriptors in
screening. Indeed most of the examples in organometal-
lic catalysis have used and adapted tools from this area
[13, 43]. While such molecules may be of interest to
organometallic chemists as synthetic targets and appli-
cation examples for novel catalysts, an exploration of
this area lies outside the scope of the present review.
Note that it has been reviewed extensively, see e.g. refs
[20, 45–49]. In this area, the need for greater diversity
in terms of the structural scaffolds used is a persistent
theme [50–52] and novel catalytic routes may open up
greater diversity in the future.
Studies aimed at selection and screening thus use a
broad range of descriptors. However, in very general
terms, large libraries are usually associated with descrip-
tors that are cheap to calculate from basic connectivity
information (topological and 2D), while smaller screen-
ing studies are more likely to use quantum chemistry to
determine electronic properties from 3D structure, often
linked quite closely to the likely mechanism of reaction;
it is perhaps worth noting at this stage that the groups













Scheme 2 Alkene metathesis
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ganometallic catalysis over long time periods, thus accom-
modating the computational efforts necessary. Similarly,
combinatorial building approaches are most likely to be
used where large and diverse databases are of interest,
whereas smaller-scale screening can be accomplished
without such automation. In addition, many of these
studies reach beyond structural similarity and often use
a figure-of-merit which is related to the descriptor data
by regression models to make predictions for novel de-
signs. While for organometallic compounds database size
remains in the thousands, potentially extending to tens of
thousands, pharmaceutical virtual screening routinely ac-
cesses larger databases and even databases of known com-
pounds capture around 30 million structures [4] in this
area, necessitating compromises to reduce the computa-
tional costs of descriptor calculations. Screening maps
thus vary substantially in scale and resolution, and might
be likened in range to maps of cities and counties at the
lower end, exploring entire continents in other cases.
Focus on exploration
Analysis of known successful drug molecules by structural
descriptors has highlighted that structural diversity in this
group of compounds is relatively limited (described as
“chemical clichés” [4]), presumably constrained by known
synthetic routes as well as what might be termed “cultural
preferences” for familiar reagents and reactions. In both
organometallic catalysis and organic, drug-like chemical
space, several attempts have been made to increase diver-
sity by combining automated molecular assembly with
structural descriptors. Again, there is overlap here with
the virtual screening described above, e.g. Rothenberg’s
work on bidentate ligands [12], but figures of merit are
generally not evaluated leaving structural similarity to
known compounds as the main criterion.
Analysis of bidentate ligand space as mapped by Bristol’s
LKB-PP [34, 36] indicated relatively poor sampling of lig-
and space by ligands used experimentally, and a more de-
tailed, exploratory scan of this area of chemical space was
performed by combining known backbones with a broader
range of substituents (most experimental studies have fo-
cussed on backbones and simply used Ph substituents) to
give 275 ligand structures (Fig. 4) [35]. These were then
evaluated with the LKB descriptors developed previously
[34, 36], using DFT calculations, but calculations have
been simplified and automated more substantially tostreamline the evaluation of these ligands. Data analysis
(Fig. 5) suggested that both backbones and substituents
lead to ligand property variations and that new areas of
bidentate P,P donor ligand space could be accessed by
introducing greater variability in the substituents used ex-
perimentally. It is worth noting that this could be ex-
panded further to consider larger numbers of backbones
and substituents, this work mainly served as a proof-of-
concept.
Mapping the properties of molecules based on their
structures is a key feature of research and prediction in
the development of potential drug molecules, and here
the largest numbers of compounds have been charac-
terised computationally. Two examples are included here
to give an overview of the mapping of substrates and reac-
tion products potentially accessible to organometallic
catalysis.
The group of Reymond based in Berne aims to map
drug-like chemical space and then mine it for possible
new structures (“The Chemical Space Project”, http://
www.gdb.unibe.ch/). To date, their largest database, gen-
erated by exhaustive enumeration of chemically feasible
bonds between C, N, O, S and the halogens contains
compounds with up to 17 of these heavy atoms (GDB-
17, 1.7 × 1011 molecules) [53]. These structures have
been characterised with 42 molecular quantum numbers
(MQN), topological descriptors not requiring the opti-
misation of structures, but allowing coarse allocation to
bins of similar compounds. Although so-called polarity
counts are included, many of these descriptors focus on
molecular size. The group also reports various screening
and selection projects based on their GDB databases, ex-
ploring fragrances [54] and searching for potential re-
placements for known pharmaceuticals [4, 16, 55]. These
analyses use smaller subsets of the databases, and rely
on simplified figures of merit to predict likely perform-
ance based on the MQNs.
In contrast, the groups of Yang and Beratan argue that
the exhaustive enumeration of possible structures is not
necessary [6], describing instead a genetic algorithm de-
signed to maximise structural diversity without building
all possible compounds. This allows them to select a
representative and maximally diverse subset of the small
molecule universe (SMU), which captures similar diversity
to Reymond’s approach in fewer steps. As restrictions on
molecular size can be relaxed, this approach allows the ex-
ploration of more of chemical space (3.6 × 109 structures).
Fig. 4 Donors, substituents and backbones sampled in LKB-PPscreen. Adapted from reference [35] by permission of the Royal Society of Chemistry
and reproduced from reference [5] with permission from WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Fig. 5 Principal component score plot showing the first two principal components (PC1 and PC2) generated by analysis of the full LKB-PPscreen
database of 28 steric and electronic descriptorss, calculated for 275 ligands (see [35] for details). Each symbol corresponds to one ligand, with
colour/shape representing different substituents, and the first two PCs capture ca. 56 % of variation in data. Reproduced from ref. [35] with
permission from The Royal Society of Chemistry
Fey Chemistry Central Journal  (2015) 9:38 Page 8 of 10They use different topological descriptors, again easy to
calculate, include an evaluation of synthetic accessibility
and favour self-organising maps (SOM) for data visualisa-
tion. They have also used the resulting dataset to search
for drug-like molecules, but this is not described in detail.
These studies show that the computational exploration
of unknown chemical space is feasible, and new maps
continue to be drawn at a variety of scales, even extend-
ing to a coarse mapping of the small molecule universe,
akin to maps of the world and the visible night sky.
Conclusions
The studies summarised here show that subsets of chem-
ical space have been mapped with calculated descriptors,
ranging in sophistication from topological descriptors de-
rived from structural formulae to descriptors specific to
organometallic catalysis, extracted from quantum chem-
ical calculations. At all levels, these descriptors can, at
least coarsely, allow to distinguish and quantify the
contributions of steric and electronic effects to com-
pound properties. Where suitable response data are
available, regression models can also be derived, allow-
ing interpretation and at times predictions to be made.
However, models and maps will only ever be as good as
the data used to generate them, and even predictions
based on quantum chemical descriptors able to distin-
guish very subtle modifications to the electronic struc-
ture of catalysts will fail if the mechanism of reaction
changes, so these need to be tensioned against experi-
mental data at every opportunity.
Arguably, any calculation of structural descriptors con-
tributes to the mapping and exploration of chemicalspace, but many studies also resort to statistical approaches
to visualise results, and here principal component analysis
is perhaps most widely used. On the resulting maps of
chemical space, proximity points to greater similarity, and
such maps, as well as the underpinning descriptors, have
been used for the optimisation, screening and exploration
of compounds with different levels of resolution. It is worth
bearing in mind that PCA is not statistically robust, so
maps will change as the compound database evolves, and
that descriptors and analyses can sacrifice some of the links
with chemical behaviour to enable, for example, a larger
database to be generated. Again, tensioning analyses
against chemical insights and experimental data is invalu-
able in demonstrating the utility of large-scale mapping of
chemical space.
In the end, the map analogy is important here–just as
world maps do not have the resolution necessary to
show trees and houses, large-scale exploratory mapping
of the chemical universe is not going to translate into
sophisticated predictive models for all compounds cap-
tured, and the intended application very much deter-
mines the computational approach used. Compound
descriptor data are gaining importance in different areas
of chemistry, and are likely to play a key role in progres-
sing computational prediction to increasingly precede
chemical synthesis, but these approaches are strength-
ened by close links to experimental reality.
Endnotes
1Arguably, any property descriptor contributes to our
understanding of the chemical universe and here, while
discussion will focus on those that have been processed
Fey Chemistry Central Journal  (2015) 9:38 Page 9 of 10into 2D and 3D maps, related studies will also be
mentioned.
2These encompass theoretical approaches focussing on
the electronic structure of compounds, i.e. semi-
empirical, Hartree-Fock (HF), density functional theory
(DFT) and post-HF approaches. They are generally more
demanding of computational resources than classical
force-field approaches (molecular mechanics/MM); the
terms quantum mechanics (QM) or quantum chemistry
are also used in this context.
3The cost of a calculation arises from the processing
power and storage capacity needed, as well as the time
taken to produce the desired output. Electronic structure
methods (see previous note) are generally more expen-
sive than molecular mechanics (MM), where, with ap-
propriate parameterisation, reasonable structures can
often be obtained quickly.
4Metal-ligand binding changes substantially for differ-
ent ligand classes, and these differences are difficult to
accommodate with a single set of descriptors. Even
where this has been attempted, responsiveness of de-
scriptors may vary and PCA can pick up on these differ-
ences, showing clustering of similar ligands with limited
overlap.
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